Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-26 Purchase |
2025-03-28 4:00 pm |
ATOSSA THERAPEUTICS INC. | ATOS | Remmel H. Lawrence Director |
10,000 | $0.7 | $7,000 | 10,257 (Direct) |
View |
| 2024-04-10 Purchase |
2024-04-11 4:05 pm |
ATOSSA THERAPEUTICS INC. | ATOS | Finn Jonathan Director |
25,000 | $1.77 | $44,250 | 25,000 (Direct) |
View |
| 2023-11-15 Sale |
2023-11-17 4:01 pm |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Former EVP, CFO, & Director |
50,000 | $0.65 | $32,500 | 55 (Direct) |
View |
| 2023-06-20 Purchase |
2023-06-20 8:15 pm |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L EVP & CFO |
50,000 | $0.97 | $48,500 | 50,055 (Direct) |
View |
| 2021-07-02 Sale |
2021-07-07 4:29 pm |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
107,497 | $5.58 | $599,833 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-27 Option Award |
2024-07-01 4:00 pm |
N/A 2034-06-27 |
ATOSSA THERAPEUTICS INC. | ATOS | Finn Jonathan Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2024-06-27 Option Award |
2024-07-01 4:00 pm |
N/A 2034-06-27 |
ATOSSA THERAPEUTICS INC. | ATOS | Remmel H. Lawrence Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2024-06-27 Option Award |
2024-07-01 4:00 pm |
N/A 2034-06-27 |
ATOSSA THERAPEUTICS INC. | ATOS | Steinhart Richard I Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2024-06-27 Option Award |
2024-07-01 4:00 pm |
N/A 2034-06-27 |
ATOSSA THERAPEUTICS INC. | ATOS | Chen Shu-Chih Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2024-06-27 Option Award |
2024-07-01 4:00 pm |
N/A 2034-06-27 |
ATOSSA THERAPEUTICS INC. | ATOS | Rees Heather SVP, Finance and Accounting |
577,700 | $0 | 577,700 (Direct) |
View |
| 2024-06-27 Option Award |
2024-07-01 4:00 pm |
N/A 2034-06-27 |
ATOSSA THERAPEUTICS INC. | ATOS | QUAY STEVEN C President & CEO |
1,795,100 | $0 | 1,795,100 (Direct) |
View |
| 2024-06-27 Option Award |
2024-07-01 4:00 pm |
N/A 2034-06-27 |
ATOSSA THERAPEUTICS INC. | ATOS | Galli Stephen J Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2024-06-27 Option Award |
2024-07-01 4:00 pm |
N/A 2034-06-27 |
ATOSSA THERAPEUTICS INC. | ATOS | Cigler Tessa Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2024-03-09 Option Award |
2024-03-14 8:35 pm |
N/A 2034-03-09 |
ATOSSA THERAPEUTICS INC. | ATOS | Cigler Tessa Director |
20,834 | $0 | 20,834 (Direct) |
View |
| 2023-11-15 Option Award(A) |
2023-11-15 5:03 pm |
N/A 2033-11-15 |
ATOSSA THERAPEUTICS INC. | ATOS | Finn Jonathan Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2023-11-15 Option Award |
2023-11-15 4:05 pm |
N/A 2033-11-15 |
ATOSSA THERAPEUTICS INC. | ATOS | Finn Jonathan Director |
62,500 | $0 | 62,500 (Direct) |
View |
Ownership |
2023-10-16 4:00 pm |
N/A 2030-04-09 |
ATOSSA THERAPEUTICS INC. | ATOS | Rees Heather SVP, Finance and Accounting |
0 | $0 | 661,700 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-05 09:00 am |
N/A 2033-06-01 |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L EVP & CFO |
2,600,000 | $0 | 2,600,000 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-05 7:36 pm |
N/A 2033-05-04 |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-05 7:36 pm |
N/A 2033-05-04 |
ATOSSA THERAPEUTICS INC. | ATOS | Remmel H. Lawrence Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-05 7:35 pm |
N/A 2033-05-04 |
ATOSSA THERAPEUTICS INC. | ATOS | Steinhart Richard I Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-05 7:35 pm |
N/A 2033-05-04 |
ATOSSA THERAPEUTICS INC. | ATOS | Chen Shu-Chih Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-05 7:35 pm |
N/A 2033-05-04 |
ATOSSA THERAPEUTICS INC. | ATOS | Galli Stephen J Director |
125,000 | $0 | 125,000 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 4:11 pm |
N/A 2033-03-02 |
ATOSSA THERAPEUTICS INC. | ATOS | QUAY STEVEN C President & CEO |
1,873,100 | $0 | 1,873,100 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 4:10 pm |
N/A 2033-03-02 |
ATOSSA THERAPEUTICS INC. | ATOS | Guse Kyle CFO, Gen Counsel and Secretary |
557,900 | $0 | 557,900 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 6:24 pm |
N/A 2032-05-13 |
ATOSSA THERAPEUTICS INC. | ATOS | Chen Shu-Chih Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 6:23 pm |
N/A 2032-05-13 |
ATOSSA THERAPEUTICS INC. | ATOS | Galli Stephen J Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 6:21 pm |
N/A 2032-05-13 |
ATOSSA THERAPEUTICS INC. | ATOS | Remmel H. Lawrence Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 6:20 pm |
N/A 2032-05-13 |
ATOSSA THERAPEUTICS INC. | ATOS | Steinhart Richard I Director |
50,000 | $0 | 500,000 (Direct) |
View |
| 2022-05-13 Option Award |
2022-05-16 6:19 pm |
N/A 2032-05-13 |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 5:15 pm |
N/A 2032-02-24 |
ATOSSA THERAPEUTICS INC. | ATOS | Guse Kyle CFO, Gen Counsel and Secretary |
746,667 | $0 | 746,667 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 5:15 pm |
N/A 2032-02-24 |
ATOSSA THERAPEUTICS INC. | ATOS | QUAY STEVEN C President & CEO |
1,900,000 | $0 | 1,900,000 (Direct) |
View |
| 2021-07-02 Tax Withholding |
2021-07-07 4:29 pm |
N/A N/A |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
57,084 | $6.4 | 0 (Direct) |
View |
| 2021-07-02 Exercise |
2021-07-07 4:29 pm |
N/A N/A |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
45,000 | $2.52 | 0 (Direct) |
View |
| 2021-07-02 Exercise |
2021-07-07 4:29 pm |
N/A N/A |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
70,000 | $1.7 | 0 (Direct) |
View |
| 2021-07-02 Exercise |
2021-07-07 4:29 pm |
N/A N/A |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
4,581 | $5.64 | 0 (Direct) |
View |
| 2021-07-02 Exercise |
2021-07-07 4:29 pm |
N/A N/A |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
164,581 | $0 | 0 (Direct) |
View |
| 2021-07-02 Exercise |
2021-07-07 4:29 pm |
N/A N/A |
ATOSSA THERAPEUTICS INC. | ATOS | WEAVER GREGORY L Director |
45,000 | $2.38 | 0 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 4:18 pm |
N/A 2031-05-14 |
ATOSSA THERAPEUTICS INC. | ATOS | Galli Stephen J Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 4:18 pm |
N/A 2031-05-14 |
ATOSSA THERAPEUTICS INC. | ATOS | QUAY STEVEN C President & CEO |
1,900,000 | $0 | 1,900,000 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 4:18 pm |
N/A 2031-05-14 |
ATOSSA THERAPEUTICS INC. | ATOS | Guse Kyle CFO, Gen Counsel and Secretary |
850,000 | $0 | 850,000 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 4:18 pm |
N/A 2031-05-14 |
ATOSSA THERAPEUTICS INC. | ATOS | Chen Shu-Chih Director |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 4:18 pm |
N/A 2031-05-14 |
ATOSSA THERAPEUTICS INC. | ATOS | QUAY STEVEN C President & CEO |
1,900,000 | $0 | 1,900,000 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 4:18 pm |
N/A 2031-05-14 |
ATOSSA THERAPEUTICS INC. | ATOS | Remmel H. Lawrence Director |
50,000 | $0 | 50,000 (Direct) |
View |